Dr. Karamlou is the Director of Clinical Research with Arizona Oncology in the Phoenix division with special interest and expertise in Hematologic Malignancies (CLL, Myeloma, MDS, MPN and Acute Myeloid Leukemia). Dr. Karamlou brings over 10 years of experience in directing clinical trial programs. While with Arizona Oncology he has helped expand access to state of the art clinical trials in the East Valley through collaboration with US Oncology Network and pharmaceutical companies.
Dr. Karamlou is also a member of the hematologic malignancy steering Committee at US Oncology and has been named Top Oncologist and Hematologist locally and nationally.